News & Publications – Page 3 – Clinical Pharmaceutical Sciences

2025

November 1, 2025

The evaluation of interactions between multiple intrinsic and extrinsic factors reported in labeling for FDA-approved drugs

Bailey SL, Stern S, Dahmane E, Ramamoorthy A, Pacanowski M, Schuck R.

J Clin Pharmacol. 2025 Nov;65(11):1392-1401. DOI: 10.1002/jcph.70064. Epub 2025 Jun 26. PMID: 40571648.

November 1, 2025

Will pig organ xenotransplantation in patients complicate the use of commonly administered drugs?

Vasudev K, Venkataramanan R, Terashita M, Maenaka A, Gupta A, Shaik I, Cooper DKC.

Xenotransplantation. 2025 Nov-Dec;32(6):e70094. DOI: 10.1111/xen.70094. PMID: 41293913.

October 7, 2025

Pericardial effusions and sotatercept therapy in pulmonary arterial hypertension: A multicenter real-world experience

Sahay S, Villasmil Hernandez N, Al Aaraj Y, Argula RG, Bernardo RJ, Chavarria M, Ibecheozor C, Coons JC, Domsic RT, Fortin T, Goodrich-Harris A, Hickey G, Ho T, Kliner J, Machado RF, Rajagopal S, Risbano MG, Sese DG, Thenappan T, Chan SY.

Eur Respir J. 2025 Aug 7:2501040. DOI: 10.1183/13993003.01040-2025. PMID: 40774808.

September 25, 2025

Factors associated with initiation of sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide 1 receptor agonists in patients with diabetes and kidney disease: A post hoc analysis of the Kidney CHAMP Trial.

Lavenburg LU, Mosslemi M, Han Z, Weltman MR, Alghwiri A, Fischer G, Rollman BL, Yabes JG, Jhamb M.

Diabetes Spectr. 2025 Sept 25; 38(4):512-524. DOI: 10.2337/ds25-0046. PMID 41257235.

September 16, 2025

Antiretroviral therapy and anesthesia: Considerations for lenacapavir

Devanathan AS, Van Ham RJ.

Anesth Analg. 2026 Jan 1;142(1):e1-e2. DOI: 10.1213/ANE.0000000000007770. PMID: 40956758.

September 15, 2025

Anal sex and tenofovir douche sequence impacts colorectal distribution of HIV surrogate and douche: DREAM-02

Zheng R, Fuchs EJ, Nimmagadda S, Rohan LC, Wang L, Bertagnolli LN, Massih S, Caffo BS, Hendrix CW.

J Infect Dis. 2025 Sep 15;232(3):588-595. DOI: 10.1093/infdis/jiaf286. PMID: 40447283.

September 5, 2025

Pharmacogenomics of buprenorphine – a narrative review

Aravindan L, Velu S, Sivam I, Sivam S, Tallapaneni PS, Ressler R, Marks M, Venkataramanan R, Radhakrishnan R, Sadhasivam S.

Pharmacogenomics. 2025 May-Jun;26(7-9):263-270. DOI: 10.1080/14622416.2025.2546770. PMID: 40908813.

August 25, 2025

Understanding clinician preferences to support pharmacogenomic results in electronic health records: A qualitative study in an academic health system.

Dreikorn EN, Sacchi S, Riden K, Empey PE, Massart MB, Berenbrok LA.

J Am Pharm Assoc (2003). 2025 Aug 25:102912. DOI: 10.1016/j.japh.2025.102912. PMID: 40865680.

August 17, 2025

Outcomes associated with time in therapeutic range for patients receiving intravenous unfractionated heparin

Mahmud M, Klimatcheva M, Tsang A, La A, Miklus V, Becker J, Herrmann B, Cremeans A, Benedict NJ, Iasella CJ, Smith RE, Coons JC

Clin Appl Thromb Hemost. 2025 Jan-Dec:31:10760296251371003. DOI: 10.1177/10760296251371003. PMID: 40820311.

August 13, 2025

Medication optimization clinic: Answering a call to action

Coons JC, Kliner J, Mathier MA, Keebler ME.

JACC Heart Fail. 2025 Aug 13;13(10):102561. DOI: 10.1016/j.jchf.2025.102561. PMID: 40811937.

All Publications